Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptional profiling of mesothelioma and mesothelial cell lines treated with brefeldin A

ABSTRACT: This study investigates the transcriptional response of mesothelioma cell lines to low-dose brefeldin A. Gene expression profiles were compared to untreated controls to identify transcriptional signatures associated with selective cytotoxicity.

ORGANISM(S): Homo sapiens

PROVIDER: GSE312181 | GEO | 2025/12/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Transcriptional profiling of mesothelioma and mesothelial cell lines treated with brefeldin A

Project description:Transcriptional profiling of mesothelioma and mesothelial cell lines treated with brefeldin A

| PRJNA1372619 | ENA

Identification of novel markers of the mesothelial lineage and mesothelioma

Project description:Microarray expression arrays on mesothelium and other tissues dissected from mice were used to identify candidate mesothelial lineage markers. These were then tested by qRTPCR across a panel of human mesothelioma cells lines, other cancers, and normal primary cells includidng mesothelial cells.

2011-12-18 | GSE30793 | GEO

Identification of novel markers of the mesothelial lineage and mesothelioma

2011-12-18 | E-GEOD-30793 | biostudies-arrayexpress

Estrogen-like activity and dual roles in cell signaling of brefeldin A

Project description:Comparing the expression profiles of the genes in response to 17b-estradiol (E2) and brefeldin A (BFA)

2014-01-01 | GSE33851 | GEO

Gene expression profiling of HepG2 cells after treatment with Brefeldin A

Project description:To investigate the effects of the Golgi disruptor on liver cancer cells, we explored a global gene expression of HepG2 cells after treatment with Brefeldin A.

2017-09-01 | GSE94861 | GEO

Transcription profiling of human mesothelioma cells MPP-89 REN compared to mesothelial cells HMC-TERT

Project description:gene expression profile of mesothelioma cells (MPP-89; REN) compared to mesothelial cells (HMC-TERT)

2008-10-09 | E-MEXP-1701 | biostudies-arrayexpress

Transcription profiling of human mesothelioma cells (MPP-89, REN) compared to mesothelial cells (HMC-TERT)

Project description:gene expression profiles of mesothelioma cells (MPP-89, REN) compared to mesothelial cells (HMC-TERT)

2008-10-09 | E-MEXP-1700 | biostudies-arrayexpress

Gene expression changes between primary mesothelioma tumour cells and commercially available cell lines, compared to normal primary mesothelial cells

Project description:Malignant mesothelioma (MM) is an aggressive, fatal tumour strongly associated with asbestos exposure. There is an urgent need to improve MM patient outcomes and this requires functionally validated pre-clinical models. Mesothelioma-derived cell lines provide an essential and robust tool widely used for candidate drug evaluation. Although a number of cell lines are commercially available, a detailed comparison of these lines with freshly-derived primary tumour cells to validate their suitability as pre-clinical models is lacking. Patient-derived primary mesothelioma cell lines were established and characterised by gene expression profiling. Molecular profiling revealed a significantly different transcriptome in commercially available compared with primary cell lines. Primary mesothelioma cell lines are more representative of the tumour close to its native state and show a degree of molecular diversity, thus capturing the disease heterogeneity in a patient cohort.

2018-02-01 | E-MTAB-6351 | biostudies-arrayexpress

Transcription profiling of two mesothelioma cell lines (MPP89 and REN), and of HMC-TERT non tumoral mesothelial cells

Project description:miRNA profile analysis of two mesothelioma cell lines (MPP89 and REN), and of HMC-TERT non tumoral mesothelial cells

2008-10-09 | E-MEXP-1699 | biostudies-arrayexpress

RNA-seq of MV4;11 cells treated with Methyl Bestatin or Brefeldin A

Project description:We report the application of RNA-seq for profiling gene transcription upon treatment of methyl bestatin (MeBs, aminopeptidase inhibitor) or brefeldin A (BFA, ER-to-Golgi transport inhibitor), compared to DMSO control. We found MeBs and BFA similarly upregulated genes pertinent to proteotoxic stress.

2022-11-15 | GSE200454 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data